Fast Locator 2012-2013: Covance - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Fast Locator 2012-2013: Covance


Covance Outsourcing Services

Year Founded:

1997

Regions where services are provided:

North America, Asia, Europe.

Number of Employees:

501+

Annual Revenues:

$500 million+

Outsourcing services provided:

Analytical Services

  • Bioanalytical testing
  • Chemistry & stability
  • Microbiology
  • Particle characterization
  • Product characterization

Consulting Services

  • Regulatory, Validation, IT, & QA/QC Services

Development and Phase I/II CTM

  • API–small molecule

API Production Technologies

  • Acetylenic chemistry
  • Acylation
  • Amidation
  • Amino acids and analogs
  • Asymmetric synthesis or chiral chemistry
  • Cyanide chemistry
  • Nitration
  • Organometallic chemistry
  • Sulfonation

Website:

www.covance.com

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
20%
Attracting a skilled workforce
28%
Obtaining/maintaining adequate financing
12%
Regulatory compliance
40%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here